Wird geladen...
Regulation of VEGF by mevalonate pathway inhibition in breast cancer
Aminobisphosphonates are used for the treatment of benign and malignant bone disorders. As inhibitors of the mevalonate pathway they exert direct anti-tumor effects in vitro and in preclinical models of bone metastases. Bisphosphonates are thought to have an anti-angiogenic activity as decreased lev...
Gespeichert in:
| Veröffentlicht in: | J Bone Oncol |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723384/ https://ncbi.nlm.nih.gov/pubmed/26909280 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2013.05.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|